BIMI Stock Plummets 16.67% Amid Lack of Institutional Ratings

Author's Avatar
Nov 15, 2024

Bimi International Medical Inc. (BIMI, Financial) experienced a significant stock drop, plunging by 16.67%. The stock is currently trading at $0.008 per share with a trading volume of 207 shares, reflecting a 0.00% turnover and volatility.

Recent financial reports indicate that BIMI recorded a revenue of $2.52 million, a net loss of $3.01 million, and an earnings per share (EPS) of -$0.49. The company's gross profit stood at $115,155, with the price-to-earnings (P/E) ratio being -0.00. As of now, there are no institutional recommendations for buying, holding, or selling the stock.

In the broader pharmaceutical retail industry on the U.S. OTC market, the sector has seen a modest increase of 0.02%. Among BIMI's peers, companies like Sunlink Health Systems, Inc., and Scienture Holdings, Inc. have registered significant gains. Meanwhile, Walgreens Boots Alliance, Petmed Express, Inc., and High Tide Inc. have shown notable activity with turnover rates of 1.42%, 0.68%, and 0.32% respectively. Petmed Express, Inc., Scienture Holdings, Inc., and Walgreens Boots Alliance have exhibited higher volatility with fluctuations of 6.11%, 5.64%, and 4.98% respectively.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.